Quaternary Ammonium Compounds Market To Reach $1.52 Billion By 2030

Quaternary Ammonium Compounds Market Growth & Trends

The global quaternary ammonium compounds market size is expected to reach USD 1.52 billion by 2030, expanding at 4.3% CAGR from 2023 to 2030, according to a new study by Grand View Research, Inc. The growth is majorly driven by the growing awareness regarding healthcare-associated infections (HAIs) amongst consumers. Healthcare-associated infections pose a significant challenge for healthcare providers across the globe. Quaternary ammonium compounds (QACs) are extensively used in hospitals and healthcare settings as disinfectants and surface sanitizers to prevent the spread of pathogens and reduce the risk of HAIs. The increasing emphasis on infection control measures and the need to maintain a sterile environment in healthcare facilities drive the demand for QAC-based disinfectants.

QACs are extensively used as active ingredients in disinfectants and sanitizers for healthcare facilities, food processing plants, laboratories, and household cleaning. They effectively kill a broad spectrum of microorganisms, including bacteria, viruses, and fungi, making them valuable for maintaining hygiene and preventing the spread of infections.The product is also used in fabric softeners to provide antistatic properties, reduce wrinkles, and improve the softness of fabrics. They help prevent static cling, make clothes easier to iron, and give a pleasant scent.

Europe is expected to dominate the market over the forecast period accounting for a revenue share of over 31% in 2022. European countries have implemented regulations and standards for the use of disinfectants and antimicrobial agents, ensuring their efficacy and safety. QACs that meet the regulatory requirements and have obtained necessary approvals for specific applications can gain wider acceptance in the market.

 Request a free sample copy or view report summary: Quaternary Ammonium Compounds Market Report

Quaternary Ammonium Compounds Market Report Highlights

• In 2022, DDAC emerged as the dominant product segment contributing over 54% of the revenue share owing to their relatively low toxicity compared to some other disinfectants and sanitizers

• Fabric softeners application segment is predicted to grow at the highest CAGR of 4.9% as these compounds are compatible with various ingredients commonly found in fabric softeners such as surfactants, emulsifiers, and fragrances

• Offline distribution channel is expected to hold the largest revenue share of over 63% in 2022. The growth of these channels is driven by knowledgeable sales representatives who provide technical guidance and support to customers

• North America is projected to grow at a significant CAGR of 4.4% over the forecast period owing to stringent hygiene and safety standards for food and beverage industry in the region

Quaternary Ammonium Compounds Market Segmentation

Grand View Research has segmented the global quaternary ammonium compounds market based on product, application, distribution channel, and region:

Quaternary Ammonium Compounds Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• ATAC

• BAC

• DDAC

• Other Products

Quaternary Ammonium Compounds Distribution Channel Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Online

• Offline

Quaternary Ammonium Compounds Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Disinfectants

• Fabric Softeners

• Wood Preservatives

• Surfactants

• Anti-static Agents

• Other Applications

Quaternary Ammonium Compounds Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

List of Key Players in the Quaternary Ammonium Compounds Market

• Arkema

• BASF SE

• DuPont

• Evonik AG

• Ashland

• Novo Nordisk Pharmatech

• Global Amines Company Pte. Ltd.